Vanguard reports 2.75M shares (5%) of Mativ
Mativ Holdings Inc — Schedule 13G filing by Vanguard Capital Management.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Mativ Holdings Inc — Schedule 13G filing by Vanguard Capital Management. The filing reports 2,747,811 shares of Common Stock beneficially owned, equal to 5% of the class, with 353,828 shares of sole voting power and 2,747,811 shares of sole dispositive power. The disclosure is signed by Vanguard's Head of Global Fund Administration on 04/30/2026.
Key Figures
Key Terms
Schedule 13G regulatory
Beneficially owned regulatory
Sole dispositive power regulatory
Investment Company Act of 1940 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Vanguard Capital Management's Schedule 13G filing for MATV mean?
Who signed the Schedule 13G on behalf of Vanguard for MATV?
Does the filing identify other persons with more than 5% interest in MATV?
AI-generated analysis. How Rhea-AI works. Not financial advice.